Table 2 Outcomes after surgery + IOERT +/- EBRT for primary/recurrent renal cell carcinoma
Series | Primary/recurrent | f/u med (y) | Median IORT dose (Gy) | Median EBRT dose (Gy) | EBRT number | 3-y OS (%) | Local control |
|---|---|---|---|---|---|---|---|
Pamplona[13] | 8/3 | 0.7 | 15 | 30-45 | 7/15 | Not stated | 10/11 |
San Francisco[14] | 0/10 | 5.9 | 15 | none | 0/10 | 36 | 8/10 |
Mayo[10] | 3/19 | 9.9 | 13.5 | 48 | 21/22 | 50 | 17/22 |
Madrid-Pamplona (pooled)[11] | 15/10 | 22.2 | 14 | 44 | 15/25 | 38 | 21/25 |
Current study | 0/17 | 1.5 | 15 | 40 | 11/17 | 63 | 15/17 |